Unveiling Precision Medicine: Transforming Healthcare with Tailored Treatments
Summary: This article by David Blivin (President & CEO, Cottonwood Technology Fund) discusses how precision medicine is transforming healthcare by customizing diagnostics and therapies based on individual genetics, lifestyle, and environment—moving from a one-size-fits-all model to targeted interventions.
Key Highlights:
- Definition & promise: Precision medicine aims to provide “the right drug to the right patient in the right dose at the right time.”
- Successful fields: Oncology has led the way with targeted therapies based on biomarkers and genomics.
- Expanding domains: The article explores opportunities in cardiology, infectious disease, and immunology as precision approaches extend beyond cancer.
- Emerging tools: Biomarkers, AI, long-read sequencing, and novel molecular platforms like circular RNAs are highlighted as next-generation levers for personalization.
- Challenges: Barriers include cost, data integration, clinical translation, regulatory pathways, and equitable access.
Read the full article on Medical Tech Outlook
Keywords:
David Blivin,
precision medicine,
personalized therapy,
biomarkers,
circular RNAs,
genomics,
biomedical innovation